Punch & Associates Investment Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Punch & Associates Investment Management’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-237,162	Closed	-$754K	–	179
2014 Q4	$754K	Hold	237,162	–	–	0.1%	161
2014 Q3	$1.92M	Hold	237,162	–	–	0.27%	140
2014 Q2	$2.48M	Hold	237,162	–	–	0.33%	125
2014 Q1	$2.15M	Buy	237,162 +122,775	+107%	+$728K	0.29%	133
2013 Q4	$543K	Buy	+114,387	New	+$535K	0.07%	166

Other funds holding BSTG

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Punch & Associates Investment Management's BSTG Position: Q1 2015 in Review

Punch & Associates Investment Management sold out of Biostage, Inc. Common Stock (BSTG) in Q1 2015, closing a stake of 237,162 shares — an estimated $754K sold.

Punch & Associates Investment Management first reported a position in BSTG in Q4 2013 and held it in 5 quarters. The position peaked at $2.48M in Q2 2014. 37 funds tracked by Wall St. Rank hold BSTG as of Q1 2015.

Punch & Associates Investment Management reported no remaining Biostage, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
Punch & Associates Investment Management sold 237,162 Biostage, Inc. Common Stock shares in Q1 2015, an estimated $754K.
Punch & Associates Investment Management first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 5 quarters.
Punch & Associates Investment Management's Biostage, Inc. Common Stock position peaked at $2.48M in Q2 2014.
37 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q1 2015.

Based on Punch & Associates Investment Management's 13F filing for Q1 2015, filed 29 Apr 2015.